PET scans in radiotherapy planning of lung cancer.
Especially for non-small cell lung cancer, FDG-PET has in the majority of the patients led to the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and, experimentally, redistribution of radiation doses within the tumor. In limited-disease small cell lung cancer, the role of FDG-PET is emerging.
De Ruysscher
Dirk
D
Department of Radiation Oncology (MAASTRO Clinic), Maastricht University Medical Center, GROW Research Institute, The Netherlands. dirk.deruysscher@maastro.nl
Kirsch
Carl-Martin
CM
D002289:Carcinoma, Non-Small-Cell Lung / Q000532:radiotherapy; D018288:Carcinoma, Small Cell / Q000532:radiotherapy; D015687:Cell Hypoxia; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000532:radiotherapy*; D049268:Positron-Emission Tomography / Q000379:methods*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*